Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This is a metadata-level update to the page template and does not alter study content or functionality.
    Difference
    0.0%
    Check dated 2026-08-06T23:08:54.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A new citation for Lenvatinib plus pembrolizumab outcomes (KEYNOTE-775/LEAP-001) has been added to the Publications section, listing the authors and journal details. The previous 'Online ahead of print' note has been removed.
    Difference
    0.0%
    Check dated 2026-07-30T19:11:35.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page received a minor revision update to version v3.6.4, signaling a small maintenance patch rather than changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-23T15:20:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page's revision history now includes a new Revision: v3.6.3 and removes the previous Revision: v3.6.1, indicating an updated document version.
    Difference
    0.0%
    Check dated 2026-07-02T03:11:21.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.1, replacing the previous v3.6.0. This reflects a newer revision of the page content rather than any changes to the study information.
    Difference
    0.0%
    Check dated 2026-06-24T23:14:01.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer recruit participants, signaling the study has stopped enrolling. The page also adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the site revision to v3.6.0, with minor header formatting adjustments to Intervention/Treatment.
    Difference
    0.2%
    Check dated 2026-06-10T12:48:23.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.